Please provide your email address to receive an email when new articles are posted on . The submission is supported by positive data from the phase 3 BRIO-I and BRIO-II studies. If approved, Brimochol ...
If you’re over age 40 and you notice that words are starting to seem blurrier when you read, you’re not going crazy. There’s a good chance you’re experiencing presbyopia. Presbyopia is an age-related, ...
A Prescription Drug User Fee Act target date of January 28, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for Brimochol ™ ...
Please provide your email address to receive an email when new articles are posted on . Vuity, an eye drop for the treatment of presbyopia, is now available, according to a press release from AbbVie. ...
New eye drops can help aging people see better – an optometrist explains how Vuity treats presbyopia
Add Yahoo as a preferred source to see more of our stories on Google. When people get into their 40s and beyond, their close-up vision starts to worsen. For many people, cranking up the font size on a ...
EDOF technology, previously used in intraocular lenses, is now available in contact lenses, offering significant improvements ...
A new once-a-day eye drop designed to improve blurry vision in adults is now commercially available in the United States. The product, known as VIZZ 1.44%, offers a nonsurgical option for people ...
The US Food and Drug Administration for the first time has approved an eye drop to treat presbyopia, also known as age-related blurry near vision, in adults. Pilocarpine HCl ophthalmic solution 1.25% ...
Deseyne ® (vifilcon C) Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia with Extended Depth of Focus (EDOF) Delivers Continuous Vision at All Distances—Redefining Presbyopia Correction ...
The FDA approved aceclidine 1.44% ophthalmic solution (Vizz) for adults with presbyopia, or age-related blurred near vision, maker Lenz Therapeutics announced on Thursday. It marks the first ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal ...
BOSTON — The investigational Raindrop transparent hydrogel corneal inlay (ReVision Optics) is consistently effective in the correction of presbyopia, relatively easy to implant, and has high patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results